WednesdaySep 16, 2020 11:05 am

Predictive Oncology Inc. (NASDAQ: POAI) Confirms Attendance at Upcoming LD 500 Microcap Investor Conference

Predictive Oncology presenting at upcoming LD 500 investor conference Investor event will take place Sept. 1-4, 2020 and will feature 500 handpicked companies from across North American listed micro-cap universe Predictive Oncology specializes in applying data and artificial intelligence to cancer personalized medicine, drug discovery Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has announced that it will be presenting at the upcoming LD 500, an investor conference set to take place in an entirely virtual setting Sept. 1-4, 2020 (http://ibn.fm/42UBB). With 500 handpicked companies…

Continue Reading

WednesdaySep 16, 2020 10:57 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Partners with Chocolatier to Offer Cannabis-Infused Chocolates

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has signed a letter of intent with Quebec-based Chocolatier to produce a new line of premium cannabis-infused, organic chocolate at its Valleyfield site. The new product line, part of TGOD’s strategic plans for expansion, will feature high-quality Belgian chocolate and organic gourmet ingredients. The announcement follows TGOD’s decision to transform its licensed Valleyfield facility into a processing hub to support its expanding product portfolio, reducing the company’s reliance on third parties and providing enhanced agility and increased quality control. "As we conducted a complete…

Continue Reading

WednesdaySep 16, 2020 10:28 am

180 Life Sciences Corp. Pursuing Novel Solutions to Inflammatory Illnesses as Merger Nears Completion

180 Life Sciences is a clinical-stage biotechnology company that is developing therapies to combat inflammation in patients with chronic inflammation-related illnesses The company is being acquired by special purpose acquisition corporation KBL Merger Corp. IV (NASDAQ: KBLM) (NASDAQ: KBLMR) (NASDAQ: KBLMW) and will be listed on the Nasdaq Capital Market under ticker symbol ATNF when the deal closes later this year Analysts forecast the anti-inflammatory therapeutics market will be worth $191.42 billion by 2027, growing at a CAGR of 3 percent 180 Life Sciences is completing phase 2b/3 clinical trials tackling fibrosis and inflammation-causing TNF substance aberrations The sudden and…

Continue Reading

WednesdaySep 16, 2020 9:51 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Finalizes Acquisition of LD Micro

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, has closed its previously announced agreement to acquire LD Micro, a leading data and event company serving the small and micro-cap space. Closing of the acquisition includes the issuing to LD Micro shareholders of 1.6 million shares of Class A common stock that are subject to lock-up for 36 months. In addition, SRAX will pay four $1 million quarterly installments; the first payment was made at closing. As a result, LD Micro will be a wholly owned subsidiary of SRAX. LD Micro founder and…

Continue Reading

WednesdaySep 16, 2020 9:45 am

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Secures $7.76M in Underwritten Public Offering

Creatd (NASDAQ: CRTD, CRTDW) (Formerly Jerrick Media Holdings Inc.), the parent company and creator of the Vocal platform, Tuesday announced the closing of its public offering of 1,725,000 units of securities at $4.50 per unit, for total proceeds of $7,762,500. According to the update, each unit consisted of one share of the company's common stock and one warrant to purchase one share of common stock, the warrant immediately exercisable at a price of $4.50 per share and expiring five years from the date of issuance. The company's common stock and warrants began trading on the Nasdaq Capital Market on September…

Continue Reading

TuesdaySep 15, 2020 3:06 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Issues Update Regarding Ongoing Disclosure Review

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) continues to work with the British Columbia Securities Commission to address an ongoing continuous disclosure review. According to the update, the company has arranged for the following since the review commenced: Filing of business acquisition reports in connection with the acquisitions of Artisan Growers Ltd., Novo Formulations Ltd. and Tassili Life Sciences Corp.; revocation of the initial cease trade order issued by the Commission on June 19, 2020; preparation of financial disclosure in connection with the acquisition of AltMed Capital Corp. (“AltMed”). The company expects this work to be concluded shortly, as…

Continue Reading

TuesdaySep 15, 2020 1:09 pm

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) Eyes Advertising Model to Further Drive Monetization, Revenue Growth

The Movie Studios (OTC: MVES), an independent motion-picture production and distribution company, is positioned for opportunity in the over-the-top media (“OTT”) sector, which has witnessed an astonishing surge in popularity over recent months. A key beneficiary of this trend, The Movie Studio’s OTT platform presents significant potential to tap revenue streams through platform ownership and as it attracts advertisers. A recent article discussing this reads, “The Movie Studio has long distinguished itself through the introduction of a series of innovative measures designed to boost the popularity of the company’s eponymous OTT platform, such as the MovieSodes feature – which enables…

Continue Reading

TuesdaySep 15, 2020 12:48 pm

QualityStocksNewsBreaks – Cannabis Global Inc. (CBGL) Announces New Hemp You Can Feel(TM) Sweetener Product Line

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, is introducing the industry’s first no-taste, nonclouding, chemical-free hemp product line. CBGL’s revolutionary Hemp You Can Feel Sweeteners is the first hemp and cannabinoid-rich offering that delivers sweetening for both beverages and food in a cloud-free, 100% water-soluble format. The product contains no  chemicals, additives, or GMOs. Using unique noninfused honey-bee hemp and cannabinoid technologies, the innovative product line fills consumer demand for all-natural options. Cannabis Global will begin shipping Hemp You Can Feel Sweeteners to customers next week. "Just over a year ago, we…

Continue Reading

TuesdaySep 15, 2020 12:42 pm

QualityStocksNewsBreaks – Why 180 Life Sciences Corp. Is ‘One to Watch’

180 Life Sciences, a clinical-stage biotechnology company, is focused on the development of novel drugs that fulfill unmet needs for a variety of conditions including fibrosis, pain and inflammatory diseases. 180 Life Sciences will soon form a combined company with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC), with the new entity to be listed under ticker symbol “ATNF” on Nasdaq Capital Market. A recent article discussing the company reads, “180 Life Sciences is leading the research into solving one of the world’s biggest drivers…

Continue Reading

TuesdaySep 15, 2020 12:28 pm

QualityStocksNewsBreaks – Cybin Corp. CEO Discusses Milestones, Goals and Momentum in Exciting Emerging Industry

Cybin, a life-sciences company focused on advancing psychedelic and nutraceutical-based products, today announced that its CEO, Doug Drysdale, is featured in an exclusive audio interview with NetworkNewsWire (“NNW”) – a financial news and content distribution company and one of 50+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Drysdale provides insight into Cybin’s 2020 milestones, near-term goals and its efforts to build on the momentum of an industry that continues to ramp up. “We have secured a source of GMP psilocybin API to support our initial clinical program, and we’ve initiated a program to synthesize our own proprietary API to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered